Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The EUFOREA pocket guide for chronic rhinosinusitis
Peter W. Hellings, W.J. Fokkens, R. Orlandi, et al.
Rhinology Journal (2022)
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023
W.J. Fokkens, A-S Viskens, V. Backer, et al.
Rhinology Journal (2023)
Open Access | Times Cited: 157
Performance and Consistency of ChatGPT‐4 Versus Otolaryngologists: A Clinical Case Series
Jérôme R. Lechien, Mattheuw R. Naunheim, Antonino Maniaci, et al.
Otolaryngology (2024) Vol. 170, Iss. 6, pp. 1519-1526
Open Access | Times Cited: 23
Chronic rhinosinusitis with nasal polyps: Key considerations in the multidisciplinary team approach
Oliver Pfaar, Anju T. Peters, Camille Taillé, et al.
Clinical and Translational Allergy (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 2
ChatGPT performance in laryngology and head and neck surgery: a clinical case-series
Jérôme R. Lechien, Bianca Georgescu, Stéphane Hans, et al.
European Archives of Oto-Rhino-Laryngology (2023) Vol. 281, Iss. 1, pp. 319-333
Closed Access | Times Cited: 33
Correlation between inflammatory biomarkers and disease control in chronic rhinosinusitis with nasal polyps
Eugenio De Corso, Silvia Baroni, Stefano Settimi, et al.
International Forum of Allergy & Rhinology (2024) Vol. 14, Iss. 7, pp. 1195-1205
Open Access | Times Cited: 9
Advances in Biologic Therapies for Allergic Diseases: Current Trends, Emerging Agents, and Future Perspectives
Ewa Alska, Dariusz Łaszczych, Katarzyna Napiórkowska-Baran, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1079-1079
Open Access | Times Cited: 1
Evaluation of switching or simultaneous use of biologic treatment in patients with severe chronic rhinosinusitis with nasal polyps and severe asthma. Considerations in clinical decision making
Josje Janna Otten, Rik Johannes Leonardus van der Lans, Eugenio De Corso, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 8, pp. 1041-1049
Open Access | Times Cited: 21
EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care
Peter W. Hellings, Isam Alobid, Wilma Terezinha Anselmo‐Lima, et al.
Allergy (2023) Vol. 79, Iss. 5, pp. 1123-1133
Open Access | Times Cited: 21
Eosinophils—from cradle to grave
Miloš Jeseňák, Zuzana Diamant, Dagmar Simon, et al.
Allergy (2023) Vol. 78, Iss. 12, pp. 3077-3102
Open Access | Times Cited: 18
How to manage recurrences after surgery in CRSwNP patients in the biologic era: a narrative review
Eugenio De Corso, Stefano Settimi, Claudio Montuori, et al.
Acta Otorhinolaryngologica Italica (2023) Vol. 43, Iss. 2 (Suppl. 1), pp. S3-S13
Open Access | Times Cited: 17
The Management of Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With Biologics
A. Wautlet, Claus Bachert, Martin Desrosiers, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 9, pp. 2642-2651
Closed Access | Times Cited: 17
Adherence to Intranasal Steroids in Chronic Rhinosinusitis with Nasal Polyposis Prior to and during Biologic Therapy: A Neglected Matter
Francesca Norelli, Michele Schiappoli, Gianenrico Senna, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 1066-1066
Open Access | Times Cited: 5
Sinonasal Outcomes Obtained after 2 Years of Treatment with Benralizumab in Patients with Severe Eosinophilic Asthma and CRSwNP: A “Real-Life” Observational Study
Eugenio De Corso, Dario Antonio Mele, Angela Rizzi, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 9, pp. 1014-1014
Open Access | Times Cited: 4
Real-world comparison of T2-biologics effectiveness in severe allergic asthma with nasal polyps
Angélica Tiotiu, Nicolas Migueres, Francisco Javier González‐Barcala, et al.
Respiratory Medicine (2025) Vol. 238, pp. 107979-107979
Closed Access
Raising the bar in respiratory care by EUFOREA: report of the European Union Parliament Symposium, April 2024
Peter W. Hellings, Diego M. Conti, Xander Bertels, et al.
Frontiers in Allergy (2025) Vol. 6
Open Access
Associations between gastroesophageal reflux disease and otolaryngological diseases
Yixi Xiao, H W Zhang, Fang Zhang, et al.
Medicine (2025) Vol. 104, Iss. 11, pp. e41750-e41750
Open Access
Diagnostik und medikamentöse Therapie der chronischen Rhinosinusitis
Sven Becker
HNO (2025)
Open Access
Serum proteomics identify CSF1R as a novel biomarker for postoperative recurrence in chronic rhinosinusitis with nasal polyps
Yan Niu, Shouming Cao, Maoxiang Luo, et al.
World Allergy Organization Journal (2024) Vol. 17, Iss. 3, pp. 100878-100878
Open Access | Times Cited: 3
Nasal polyp syndrome: a patient-centred term for CRSwNP by EUFOREA
T. Teeling, C. Djouder, Henry Laurens, et al.
Frontiers in Allergy (2024) Vol. 5
Open Access | Times Cited: 3
Serum exosomal miR-141-3p and miR-3679-5p levels associated with endotype and postoperative recurrence in chronic rhinosinusitis with nasal polyps
Gang Wang, Zizhen Liu, Jiabin Zhan, et al.
World Allergy Organization Journal (2024) Vol. 17, Iss. 8, pp. 100938-100938
Open Access | Times Cited: 3
EUFOREA summit in Brussels 2023: inspiring the future of allergy & respiratory care
Peter W. Hellings, Susanne Lau, Glenis Scadding, et al.
Frontiers in Allergy (2023) Vol. 4
Open Access | Times Cited: 9
Imaging of chronic rhinosinusitis with nasal polyps in the era of biological therapies
Remo Poto, Corrado Pelaia, Antonio Di Salvatore, et al.
Current Opinion in Allergy and Clinical Immunology (2024) Vol. 24, Iss. 4, pp. 243-250
Open Access | Times Cited: 2
CD109 identified in circulating proteomics mitigates postoperative recurrence in chronic rhinosinusitis with nasal polyps by suppressing TGF-β1-induced epithelial-mesenchymal transition
Ru Gao, Yu Chen, Huihong Liu, et al.
International Immunopharmacology (2024) Vol. 130, pp. 111793-111793
Closed Access | Times Cited: 2
EUFOREUM Berlin 2023: Optimizing care for type 2 inflammatory diseases from clinic to AI: A pediatric focus
Diego M. Conti, Vibeke Backer, Beyer Kirsten, et al.
Pediatric Allergy and Immunology (2024) Vol. 35, Iss. 7
Open Access | Times Cited: 2
Thymic Stromal Lymphopoietin (TSLP): Evidence in Respiratory Epithelial-driven Diseases Including Chronic Rhinosinusitis with Nasal Polyps
Eugenio De Corso, Peter W. Hellings, Wytske J. Fokkens, et al.
Current Allergy and Asthma Reports (2024) Vol. 25, Iss. 1
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top